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Attachment of lytic peptides to the lipid membrane of virions or bacteria is often accompanied by their
aggregation and pore formation, resulting eventually in membrane rupture and pathogen neutralization. The
membrane rupture may occur gradually via formation of many pores or abruptly after the formation of the
first pore. In academic studies, this process is observed during interaction of peptides with lipid vesicles. We
present an analytical model and the corresponding Monte Carlo simulations focused on the pore formation in
such situations. Specifically, we calculate the time of the first nucleation-limited pore-formation event and show
the distribution of this time in the regime when the fluctuations of the number of peptides attached to a vesicle
are appreciable. The results obtained are used to clarify the mechanism of the pore formation and membrane
destabilization observed recently during interaction of highly active α-helical peptide with sub-100-nm lipid
vesicles that mimic enveloped viruses with nanoscale membrane curvature. The model proposed and the analysis
presented are generic and may be applicable to other meso- and nanosystems.
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I. INTRODUCTION
Nucleation of a new phase, occurring under thermody-
namically favorable conditions, is a basic physicochemical
phenomenon. It is observed in very different systems and
accordingly plays an important role in numerous applications.
For these reasons, the studies of this process have a long history
spanning over 280 years (reviewed in Ref. [1]). The classical
nucleation theory (CNT) was developed over 80 years ago by
Volmer, Weber, Becker, Doering, and Zeldovich (reviewed in
Ref. [2]). At present, this area continues to attract attention
in efforts to clarify the mechanistic details (in addition to
reviews [1,2], see, e.g., the nucleation theorems discussed
by Ford [3], more recent general studies [4], a review of the
kinetics of protein aggregation [5], and references therein).
The corresponding treatments usually imply that a medium is
macroscopic, nucleation occurs under steady-state conditions,
the subcritical nuclei of a new phase are at equilibrium with
an original metastable phase, and the number of atoms or
molecules in a critical nucleus is large. Under such conditions,
the nucleation rate is expressed via the free energy of formation
of the critical nuclei.
During the past decade, the focus of studies in natural
sciences has appreciably shifted to physicochemical and
biological meso- and nanosystems. In such systems, nucleation
often also may play an important role (see, e.g., the analysis
of melting and freezing of metal nanoparticles [6], protein
folding [7], and lipid self-assembly [8]). The interpretation of
the corresponding experimental results is often possible in the
framework of the general CNT concepts (for the shortcoming
of CNT, see, e.g., the review by Ford [2]). The practical
realization of these concepts should, however, as a rule include
novel ingredients taking the specifics of meso- or nanosystems
into account.
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To motivate our work, we refer to the experimental studies
of interaction of lytic peptides with lipid vesicles, viral
membranes, or bacteria (see reviews [9], recent experiments
[10,11], related molecular dynamics simulations [12], and ref-
erences therein). In these systems, the attachment of peptides
to the membrane is accompanied by their aggregation, pore
formation, and, sometimes, membrane rupture, which in the
case of bacteria and virions leads to pathogen neutralization.
The process may occur gradually via formation of many pores
or abruptly via membrane rupture followed the formation and
growth of the first pore. These two scenarios can experi-
mentally be distinguished and tracked by using single-vesicle
imaging as shown in recent experiments [11] with highly active
α-helical peptide and sub-100-nm vesicles. Theoretically, the
corresponding kinetics or at least the pore-formation events
can be described in the terms of nucleation theory. Direct
application of CNT may, however, be hampered here because
(i) the nucleation resulting in pore formation occurs under
transient peptide-attachment conditions, (ii) the number of
peptides (per vesicle or virion) is relatively small (from a
few hundred to a few thousand), (iii) there may be only a few
precritical nuclei, and (iv) the critical nucleus may include
only a few peptides. For the first scenario implying the vesicle
rupture following the formation of many pores, reservations
of this type are often not crucial (especially if one is primarily
interested in rupture) and the corresponding models have
already been proposed and correlated with experimental results
(see, e.g., Ref. [13]). For the second scenario with the rupture
following the formation of the first pore, the reservations
indicated are more restrictive and, in addition, some of the
questions raised are different from those customarily addressed
by CNT. For example, the nucleation rate is not central in this
case. What is often more interesting and practically important
is the time of the first nucleation event, referred to below as the
first-passage time tFP, and the distribution of this time related
to fluctuations of the number of peptides associated with a
vesicle.
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Employing a generic kinetic model of peptide-induced and
nucleation-limited pore formation in vesicles, we have recently
derived an analytical expression for tFP [11]. In our present
work, using the same model, we briefly describe and extend
the earlier analysis [Eqs. (1)–(11) in Sec. II], derive analytical
expressions allowing one to estimate the role of fluctuations in
the distribution of tFP [Eqs. (12)–(14) in Sec. II], present Monte
Carlo (MC) simulations (Sec. III) focused on these aspects of
the kinetics, and illustrate how the results obtained may help
to interpret the experiment (Sec. IV).
II. ANALYTICAL RESULTS
Let us consider attachment of peptides to a vesicle. This
process is assumed to be irreversible and schematically
represented as
Ps → Pa, (1)
where Ps and Pa are peptides in the solution and on the
membrane. The pore formation is considered to be limited
by nucleation including n − 1 sequential steps of association
of Pa and i-mers,
Pa + Pa  C2, (2)
Pa + Ci  Ci+1 (2  i  n − 2), (3)
Pa + Cn−1 → Cn, (4)
where Ci (2  i  n − 1) is an i-mer containing i monomers.
Step (4) is assumed to be slow compared to steps (2)
and (3). After step (4), the pore-formation process may
include association of additional peptides. The latter steps are
considered to be rapid and not treated explicitly.
Initially (at t = 0), a vesicle is set to be free of peptides. The
nucleation is assumed to occur when the number of peptides
attached to a vesicle becomes appreciable, N  n (note that
a critical nucleus typically includes only a few peptides, i.e.,
n is usually smaller than 10, which makes N  n a valid
assumption even if N is relatively small). In analogy with
CNT, we consider that the attached peptides are primarily
monomers. In other words, this means that the peptide uptake
is approximately equal to the number of monomers N  N1.
With this condition, the peptide uptake [step (1)] is described
phenomenologically as
N1 = Atα, (5)
where A is a constant and α is the corresponding exponent.
For example, α = 1 corresponds to the simplest kinetically
limited attachment kinetics or the diffusion-limited kinetics
under the flow conditions, while α = 1/2 may describe the
diffusion-limited case under no flow conditions.
In analogy with CNT, we consider that steps (2) and (3) are
close to equilibrium. In this case, the number of Cn−1 is given
by
Nn−1 = KNn−11 , (6)
where K is the equilibrium constant for the formation of Cn−1.
Substituting (5) into (6) yields
Nn−1 = KAn−1tα(n−1). (7)
The equation for the number of Cn is read as
dNn/dt = knNn−1N1, (8)
where kn is the rate constant of step (4). Substituting (5) and (7)
into (8) results in
dNn/dt = knKAntαn. (9)
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FIG. 1. (Color online) Typical dependences of N1, N2, and N3 on time for ra = 1 (a) and 10 s−1 (b). The MC kinetics (circles) were
calculated up to the first pore-formation event. The interval between the MC data point is 10 s. The MF kinetics (lines) were calculated by
using Eqs. (19)–(22) up to N4 = 1.
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Integrating (9), we obtain
Nn = knKAntαn+1/(αn + 1). (10)
The time of the first nucleation event or, in other words, the
first-passage time can be identified with reaching Nn = 1.
Using this condition and Eq. (10), we have
tFP =
(
αn + 1
knKAn
)1/(αn+1)
. (11)
In fact, this expression represents the average mean-field (MF)
first-passage time.
In an ensemble of identical vesicles, tFP is distributed
due to fluctuations of the number of peptides attached to
a vesicle. The important point is that the nucleation occurs
primarily near the average first-passage time 〈tFP〉 because the
nucleation rate [Eq. (8)] becomes appreciable when t  〈tFP〉.
According to Eq. (8), the time scale of nucleation is equal
to 1/(knNn−1N1). At t  〈tFP〉, N1 is much larger than Nn−1
and, accordingly, the fluctuations of N1 are negligible, i.e.,
one can replace N1 by 〈N1〉. The fluctuations of 1/Nn−1
can be estimated by expanding this ratio and taking into
account the part related to fluctuations, i.e., Nn−1/〈Nn−1〉2.
Following this line, we represent the deviation of tFP as
tFP = Nn−1/kn〈N1〉〈Nn−1〉2. The standard deviation of tFP
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FIG. 2. (Color online) Average first-passage time and its standard
deviation as a function of the attachment rate. The MC and MF data
are shown by circles and lines, respectively. Each MC data point
was obtained by using 5 × 103 MC runs. In the MF case, 〈tFP〉 was
calculated by using Eq. (23) and its standard deviation was obtained
by employing Eqs. (12), (14), and (21).
is accordingly given by
〈(tFP)2〉1/2 = 〈(Nn−1)
2〉1/2
kn〈N1〉〈Nn−1〉2 . (12)
Dividing the left and right parts of this expression by 〈tFP〉 and
using Eqs. (5), (7), and (11), one can rewrite it as
〈(tFP)2〉1/2
〈tFP〉 =
〈(Nn−1)2〉1/2
(αn + 1)〈Nn−1〉 . (13)
The latter expression indicates that the normalized standard
deviation of tFP is smaller than that of Nn−1 by a factor of
αn + 1.
The analysis above implies that the variance 〈(Nn−1)2〉
should be calculated by employing the Nn−1 values corre-
sponding to the nucleation events. Thus the distribution of
Nn−1 is expected to be slightly different compared to the
equilibrium distribution because the nucleation events are
more probable for larger Nn−1 and there may be deviations
from equilibrium. This difference is, however, expected to
be minor and 〈(Nn−1)2〉 can be calculated by using the
Poissonian distribution corresponding to equilibrium, i.e.,
〈(Nn−1)2〉 = 〈Nn−1〉. (14)
The formulas derived above allow one to calculate the
average time of the first nucleation event, resulting in the pore
formation, and its standard deviation. If the vesicle rupture
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FIG. 3. (Color online) Average number of precritical nuclei and
its standard deviation as a function of the attachment rate. Each MC
data point was obtained by using 5 × 103 MC runs. The MF curves
were constructed by employing Eqs. (21) and (14).
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occurs just after the formation of the first pore, the formulas
can also be directly used to interpret rupture.
III. MONTE CARLO SIMULATIONS
The accuracy of some of the steps in our analysis above
can be debated. For example, the number of subcritical nuclei
Nn−1 during the nucleation event may be low (from one to
a few copies) and one may doubt whether the MF equations
are accurate in this limit. To scrutinize such aspects, we have
performed MC simulations of the kinetics under consideration
in the case when Nn−1 is indeed low. The advantage of the
MC technique is that it allows us to simulate steps (1)–(4)
exactly without the simplifications inherent to the MF
treatment.
For example, we analyze nucleation with n = 4 (this value
of n was used to interpret the experiments in Ref. [11]). The
peptide attachment to a vesicle is considered to be kinetically
limited, i.e., α = 1. The corresponding MF equations for the
i-mer populations are
dN1/dt = ra − 2k2N21 + 2d2N2 − k3N2N1
+ d3N3 − k4N3N1, (15)
dN2/dt = k2N21 − d2N2 − k3N2N1 + d3N3, (16)
dN3/dt = k3N2N1 − d3N3 − k4N3N1, (17)
dN4/dt = k4N3N1, (18)
where ra is the attachment rate and ki and di are the peptide
association and dissociation rate constants. Employing these
equations and following the prescriptions described in Sec. II,
we have
N1 = rat, (19)
N2 = k2(rat)2/d2, (20)
N3 = k2k3(rat)3/d2d3, (21)
N4 = k2k3k4r4a t5/5d2d3, (22)
tFP =
(
5d2d3
k2k3k4r4a
)1/5
, (23)
where ra ≡ A and K ≡ k2k3/d2d3.
Our MC simulations are based on the standard Gillespie
algorithm including the calculation of the total rate of all the
possible steps wt =
∑
i wi , realization of one of the steps
chosen with probability wi/wt , and the increment of time by
|ln(ρ)|/wt , where ρ (0 < ρ  1) is a random number. In our
case, we have six steps occurring with the rates w1 = ra , w2 =
k2N1(N1 − 1), w3 = d2N2, w4 = k3N2N1, w5 = d3N3, and
w6 = k4N3N1. To obtain the kinetics on the biologically rea-
sonable time scale, the corresponding rate constants were set
as k2 = k3 = 10−5 s−1, k4 = 10−6 s−1, and d2 = d3 = 1 s−1.
In addition, ra was chosen as a governing parameter and varied
in the range from 1 to 10 s−1.
The MC and MF kinetics calculated with the specification
above are in good agreement (Fig. 1) despite the stochastic
behavior of N3. The MC and MF dependences of 〈tFP〉 on
ra are in good agreement as well (Fig. 2). For the standard
deviation of tFP, as expected, the agreement between the MC
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FIG. 4. (Color online) Distributions of tFP and N3 for ra = 1 (a) and 10 s−1 (b). The MC distribution of tFP (circles) is shown together with
the Gaussian distribution (lines) f (x) = (2π〈x〉2)−1/2 exp[−(x)2/2〈x〉2], calculated by using the same average and variance as in the MC
case. The MC distribution of N3 (solid circles) is exhibited together with the Poissonian distribution (open circles) f (N ) = 〈N〉 exp(−〈N〉)/N !,
calculated by employing the same average as in the MC case.
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and MF results is somewhat worse (Fig. 2). Specifically, the
MC deviation is larger by a factor of 1.1–2. The average value
of N3 is slightly larger in the MC case as well (Fig. 3).
The distribution of tFP is Gaussian (Fig. 4, top panels),
while the distribution of N3 exhibits, as expected (because
the Pa association with C3 is irreversible), deviations from
the Poissonian one (Fig. 4, bottom panels). The deviations are,
however, modest.
IV. APPLICATION
Our present study was initiated by the experiments per-
formed in our group [11] with the aim to clarify the mech-
anism of the pore formation and membrane destabilization
observed during interaction of highly active α-helical peptide
with sub-100-nm lipid vesicles that mimic enveloped viruses
with nanoscale membrane curvature. The distributions of the
time of the first-pore formation,F (tFP) [Figs. 5(a) and 5(b)]
were obtained from single-vesicle imaging for vesicles with
average radii of 100 and 40 nm. The distributions of vesicles
over the radius f (r) were relatively narrow [Fig. 5(c)]. With
decreasing the average vesicle radius from 100 nm to 40 nm,
〈tFP〉 is found to become appreciably shorter, i.e., tFP depends
on r and becomes shorter with decreasing r . The ratio
〈(tFP)2〉1/2/〈tFP〉 is slightly larger for smaller vesicles. In
addition, the distribution of tFP for smaller vesicles exhibits
a tail, while the distribution for larger vesicles is nearly
symmetric.
Due to the dependence of tFP on r , the experimentally
observed distributions F (tFP) depend not only on the kinetics
of pore formation (as discussed in Secs. II and III), but also
on f (r). If the latter dependence dominate, F (tFP) can be
expressed via f (r) as
F (tFP) = f (r(tFP))dr(tFP)
dtFP
, (24)
where r(tFP) is the function inverse to tFP(r).
Physically, the dependence of tFP on r may be related
to two factors. The first one is that the pore-formation rate
is proportional to the vesicle area. The second one is that
the activation energy for this process may decrease with
decreasing r due to curvature-related membrane strain (as
discussed in the other context in Ref. [14]). With decreasing
r , tFP is expected to increase according to the former factor
and decrease according to the latter factor. In the case under
consideration, as already noted, the experiment indicates that
tFP decreases with decreasing r and accordingly the curvature-
related membrane strain seems to dominate. Taking only this
factor into account, we represent the dependence of tFP on r
as [14]
tFP(r) = t◦ exp(−Ba/r), (25)
where t◦ is the value at r → ∞, a = 2.5 nm is the thickness
of the lipid layer, and B is a dimensionless parameter related
to expansion of the activation energy with respect to the lipid-
bilayer curvature.
To reproduce the position of peaks in the distributions of tFP
for vesicles with 〈r〉 = 100 and 40 nm [Figs. 5(a) and 5(b)], we
have used Eqs. (24) and (25) with t◦ = 15 min, B = 30, and the
experimentally measured vesicle size distributions [Fig. 5(c)].
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FIG. 5. (Color online) Distribution of the time of formation of
the first pore by α-helical peptide in vesicles with an average radius
of (a) 100 and (b) 40 nm. The columns show the experimental data
(reproduced from Fig. 3 in Ref. [11]). The solid lines were obtained
by taking the dependence of tFP on the vesicle radius into account
[Eqs. (24) and (25)]. (c) The distributions of vesicles over radius
were obtained by the nanoparticle tracking analysis.
The distributions F (tFP) calculated with these parameters are
shown in Figs. 5(a) and 5(b). Comparing the experimental and
theoretical results, one can notice that for smaller vesicles [with
〈r〉 = 40 nm; see Fig. 5(a)] the calculated full width at half
maximum (FWHM) of F (tFP) is comparable to that observed
experimentally (in both cases, the FWHM is approximately
equal to 1.1 min). In addition, the model reproduces the
experimentally observed asymmetry (tail) in the distribution
of tFP, which appears to be related to the corresponding
asymmetry of the size distribution of smaller vesicles. For
larger vesicles [Fig. 5(b)], the calculated FWHM (2.5 min)
is appreciably smaller than in the experiment (7 min). The
latter seems to indicate that for these vesicles the contribution
of fluctuations of the number of attached peptides to FWHM
is comparable to or slightly larger that that related to the
vesicle size distribution. This conclusion is confirmed by our
MC simulations (Fig. 4) showing that the fluctuation-related
scale of the ratio 〈(tFP)2〉1/2/〈tFP〉 may be comparable to that
observed for larger vesicles [Fig. 5(b)].
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V. CONCLUSION
Motivated by the experimental studies of interaction of lytic
peptides with lipid vesicles, virions, or bacteria, we have ana-
lyzed in detail the generic model describing peptide attachment
and peptide-induced and nucleation-limited pore formation.
The dependences of the corresponding first-passage time tFP
and its standard deviation on the model parameters have been
calculated analytically [expressions (11) and (13)] by using
the MF equations and also by employing MC simulations. The
MC simulations indicate that the MF predictions for tFP are
fairly accurate even in the situations when there are only a few
precritical nuclei. The analytical predictions for the standard
deviation of tFP are less accurate. In particular, the standard
deviation calculated analytically may be smaller compared to
the MC one by a factor of 1.1–2.
Our analysis of the standard deviation of tFP has been
focused on the role of fluctuations of the number of peptides
attached to a vesicle. The corresponding expression (13) can
be used to describe pore formation in an ensemble of vesicles
provided that they are of the same size. In real experiments,
vesicles always have some variation in size. Taking into
account that tFP depends on the vesicle size, the standard
deviation of tFP should contain the related contribution. For
a given dependence of tFP on the vesicle size, the latter
contribution to the standard deviation of tFP can be calculated
by employing Eq. (24) provided that the vesicle distribution is
known.
The results obtained have been used to interpret the recent
experiments [11] with highly active α-helical peptide and sub-
100-nm vesicles. In particular, our analysis indicates that the
contribution of fluctuations of the number of peptides, attached
to a vesicle, to the ratio 〈(tFP)2〉1/2/〈tFP〉 can be comparable
to that observed experimentally. Thus the fluctuations appear
to be manifested in the kinetics despite the effects related to
the vesicle-size distribution.
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